AbbVie Inc.ABBVNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+58.8%
5Y CAGR+20.1%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+58.8%/yr
vs -0.8%/yr prior
5Y CAGR
+20.1%/yr
Recent acceleration
Acceleration
+59.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 96.82 | +31.8% |
| 2024 | 73.48 | +30.4% |
| 2023 | 56.34 | +133.0% |
| 2022 | 24.18 | +16.5% |
| 2021 | 20.76 | -46.3% |
| 2020 | 38.70 | +132.6% |
| 2019 | 16.64 | -33.4% |
| 2018 | 24.98 | -14.1% |
| 2017 | 29.07 | +70.4% |
| 2016 | 17.06 | - |